Skip to main content

Advertisement

Log in

Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

This study aimed to evaluate the glycemic levels in Chinese patients with type 2 diabetes mellitus (T2DM) and to explore the factors related to the results of glycemic control. A total of 2454 T2DM patients from 11 communities were examined for glycosylated hemoglobin levels and glycemic control options. Potential factors related to the results of glycemic control were analyzed using logistic regression. Of all the patients, 55.3 % achieved the glycemic control target of HbA1c < 7 %. Multivariate analysis showed that male sex (OR 1.345, 95 % CI 1.022–1.769; P = 0.034), higher levels of fasting blood glucose (OR 1.954, 95 % CI 1.778–2.147; P < 0.001), and low-density lipoprotein cholesterol (OR 1.181, 95 % CI 1.020–1.367; P = 0.026) were significantly associated with poor glycemic control. The complexity of antidiabetics was also associated with poor glycemic control (P < 0.05). Compared to diet and exercise, insulin injection was most strongly associated with poor glycemic control (OR 6.210, 95 % CI 4.054–9.514; P < 0.001). Male patients with higher levels of total cholesterol, lower levels of high-density lipoprotein cholesterol, or longer diabetic durations showed poor glycemic control, which was not found in female patients. Glycemic control was not satisfactory in T2DM patients of Nanjing communities. Various factors are associated with poor results of glycemic control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310:948–59.

    Article  CAS  PubMed  Google Scholar 

  2. Rothschild SK, Martin MA, Swider SM, et al. Mexican american trial of community health workers: a randomized controlled trial of a community health worker intervention for mexican americans with type 2 diabetes mellitus. Am J Public Health. 2014;104:1540–8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Coburn KD, Marcantonio S, Lazansky R, Keller M, Davis N. Effect of a community-based nursing intervention on mortality in chronically ill older adults: a randomized controlled trial. PLoS Med. 2012;9:e1001265.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetologia. 2009;52:17–30.

    Article  CAS  PubMed  Google Scholar 

  5. Braga M, Casanova A, Teoh H, et al. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. Can J Cardiol. 2010;26:297–302.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Chinese Diabetes Society. Guidelines of prevention and treatment for Chinese type 2 diabetes. Chin J Diabetes. 2012;20:S1–37 (in Chinese).

    Google Scholar 

  7. Dailey G. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes. Clin Ther. 2011;33:665–78.

    Article  PubMed  Google Scholar 

  8. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–93.

    Article  PubMed  Google Scholar 

  9. Hogan P, Dall T, Nikolov P. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–32.

    Article  PubMed  Google Scholar 

  10. Sazlina SG, Mastura I, Ahmad Z, et al. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult diabetes control and management. Geriatr Gerontol Int. 2014;14:130–7.

    Article  PubMed  Google Scholar 

  11. de Pablos-Velasco P, Parhofer KG, Bradley C, et al. Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study. Clin Endocrinol (Oxf). 2014;80:47–56.

    Article  Google Scholar 

  12. Munshi MN, Segal AR, Suhl E, et al. Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med. 2011;171:362–4.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ismail-Beigi F. Clinical practice. Glycemic management of type 2 diabetes mellitus. N Engl J Med. 2012;366:1319–27.

    Article  CAS  PubMed  Google Scholar 

  14. Ahtiainen M, Alen M, Pollanen E, et al. Hormone therapy is associated with better body composition and adipokine/glucose profiles: a study with monozygotic co-twin control design. Menopause. 2012;19:1329–35.

    Article  PubMed  Google Scholar 

  15. Smith NL, Savage PJ, Heckbert SR, et al. Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: the Cardiovascular Health Study. J Am Geriatr Soc. 2002;50:416–23.

    Article  PubMed  Google Scholar 

  16. Akbar DH, Al-Gamdi AA, Hejazi NA. Poor lipid control in type-2 diabetics with and without ischemic heart disease. Endocrine. 2003;21:217–20.

    Article  CAS  PubMed  Google Scholar 

  17. Al Sifri SN, Almahmeed W, Azar S, et al. Results of the dyslipidemia international study (DYSIS)-middle east: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment. PLoS One. 2014;9:e84350.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Benoit SR, Fleming R, Philis-Tsimikas A, Ji M. Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study. BMC Public Health. 2005;5:36.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Willey CJ, Andrade SE, Cohen J, Fuller JC, Gurwitz JH. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Am J Manag Care. 2006;12:435–40.

    PubMed  Google Scholar 

  20. Pan C, Yang W, Jia W, Weng J, Tian H. Management of Chinese patients with type 2 diabetes, 1998–2006: the Diabcare-China surveys. Curr Med Res Opin. 2009;25:39–45.

    Article  PubMed  Google Scholar 

  21. Tan MY, Magarey J. Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic control. Patient Educ Couns. 2008;72:252–67.

    Article  PubMed  Google Scholar 

  22. Zhu VJ, Tu W, Marrero DG, Rosenman MB, Overhage JM. Race and medication adherence and glycemic control: findings from an operational health information exchange. AMIA Annu Symp Proc. 2011;2011:1649–57.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the Department of Science and Technology of Jiangsu Province [No. BS2010089] and National Natural Science Foundation of China [No. 71373132].

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rongwen Bian.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shan, S., Gu, L., Lou, Q. et al. Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study. Clin Exp Med 17, 79–84 (2017). https://doi.org/10.1007/s10238-015-0406-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-015-0406-x

Keywords

Navigation